Digital spatial profiling of α-PD-1 treated breast cancer bone metastases reveals region-specific signaling and enrichment of immune-suppressive markers
Journal of Bone Oncology · 2026-04 · 57 · 100741
DOI: 10.1016/j.jbo.2026.100741 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bone Oncology, 2026-04. Verfasst von Déja M Grant und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Meharry Medical College, Nashville, TN, United States. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Institutes of Health, US Department of Defense, Vanderbilt University.
Abstract (Originalsprache)
Bone is the most common and preferential site for breast cancer metastasis. Upon dissemination to the bone, breast cancer cells engraft into multiple niches, but it is unclear whether there are region-specific differences that may drive breast cancer progression in bone. We used a proteomic digital spatial profiling (DSP) approach to investigate which proliferation, cell death, and immune-related markers and pathways are enriched in immune and cancer cells residing 1) in the bone marrow or 2) along the endosteal surface, in an E0771, α-PD-1 treated pre-clinical model of breast cancer bone metastasis. We selected morphological markers to identify breast cancer cells and immune cells and applied a multiplexed set of probes targeting >70 proteins to characterize breast cancer and immune cell signaling in the marrow and endosteal regions using a DSP platform. We found multiple immune suppressive markers were enriched in the endosteum, including Foxp3, CD163, CD27, Pd-1, and Pd-l1, while proliferation markers were enriched in tumor cells in the marrow, including p38 Mapk, pan-Ras, Mek1, and phospho-Erk1/2. These findings shed light on the niche-specific proteins and pathways that are activated in breast cancer bone metastases and establish a user-friendly highly multiplexed approach for spatial proteomics in pre-clinical models of bone metastasis.
Autor:innen und Institutionen
- Department of Biomedical Sciences, Meharry Medical College, Nashville, TN, United States.
- Program in Cancer Biology, Vanderbilt University, Nashville, TN, United States.
- Vanderbilt Center for Bone Biology, Vanderbilt University Medical Center, Nashville, TN, United States.
- Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.
Förderung
- National Institutes of Health
- US Department of Defense
- Vanderbilt University
- Vanderbilt Cancer Center
- Howard Hughes Medical Institute
Zitieren
APA
Grant, D. M., Joseph, G. J., Searcy, M., & Johnson, R. W. (2026). Digital spatial profiling of α-PD-1 treated breast cancer bone metastases reveals region-specific signaling and enrichment of immune-suppressive markers. Journal of Bone Oncology, 57, 100741. https://doi.org/10.1016/j.jbo.2026.100741
Vancouver
Grant DM, Joseph GJ, Searcy M, Johnson RW. Digital spatial profiling of α-PD-1 treated breast cancer bone metastases reveals region-specific signaling and enrichment of immune-suppressive markers. Journal of Bone Oncology. 2026;57:100741. doi:10.1016/j.jbo.2026.100741
BibTeX
@article{Grant2026,
author = {Grant, Déja M and Joseph, Gwenyth J and Searcy, Madeline and Johnson, Rachelle W},
title = {Digital spatial profiling of α-PD-1 treated breast cancer bone metastases reveals region-specific signaling and enrichment of immune-suppressive markers},
journal = {Journal of Bone Oncology},
year = {2026},
volume = {57},
pages = {100741},
doi = {10.1016/j.jbo.2026.100741}
}
EUVIMED